AxoGen, Inc., a Florida-based company, is a leader in developing and marketing technologies for peripheral nerve regeneration and repair. The company has a global reach and offers a range of products to address the needs of patients suffering from nerve injuries. Its flagship product, the Avance Nerve Graft, is a biologically active off-the-shelf processed human nerve allograft that allows for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. In addition, the company offers the AxoGuard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves, and AxoGuard Nerve Protector, a porcine submucosa ECM product that protects damaged peripheral nerves while reinforcing nerve reconstruction and preventing soft tissue attachments. Other products include the AxoGuard Nerve Cap, a porcine submucosa ECM product that protects peripheral nerve ends and reduces the development of symptomatic or painful neuroma, and AxoTouch two-point discriminator, a tool for measuring the innervation density of the skin's surface. AxoGen, Inc. serves a broad customer base, including hospitals, surgery centers, military hospitals, and a variety of surgeons specialized in plastic reconstructive, orthopedic, and maxillofacial surgeries.
AxoGen's ticker is AXGN
The company's shares trade on the NASDAQ stock exchange
They are based in Alachua, Florida
There are 201-500 employees working at AxoGen
It is axogeninc.eu
AxoGen is in the Healthcare sector
AxoGen is in the Medical Appliances & Equipment industry
The following five companies are AxoGen's industry peers: